Published in New England Journal of Medicine · View the paper (DOI)
A new clinical trial from the University of Minnesota Medical School found that allopurinol did not slow kidney function in people with type 1 diabetes, despite reducing uric acid levels. The three-year study enrolled 530 participants and followed their glomerular filtration rate to assess kidney health.
Coverage from 2 institutions